Literature DB >> 23236923

[Anesthetic management for percutaneous transcatheter closure of atrial septal defect].

Shinichi Yamamoto1.   

Abstract

Atrial septal defect (ASD) is one of the commonest cardiac anomalies in children. Surgical repair leads to excellent results with very low morbidity and mortality, but percutaneous transcatheter closure with a septal occluder is gradually becoming an alternative method, as it is minimally invasive. Anesthesia with intubation is necessary for this procedure, because transesophageal echocardiography is essential in the evaluation of ASD and placement of the occlusion device for ASD. During the procedure, minor complications including device embolizations and arrhythmia need attention. Balloon test occlusion of atrial septal defects may identify patients with left ventricular restrictive physiology before ASD closure. Intravenous anticongestive conditioning medication might be useful for preventing congestive heart failure after interventional closure of an ASD in the patient with a restrictive left ventricle.

Entities:  

Mesh:

Year:  2012        PMID: 23236923

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience.

Authors:  Pushkar Mahendra Desai; Sanjeeta R Umbarkar; Manjula S Sarkar; Rishi Lohiya
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep

2.  Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult.

Authors:  Jae Wook Jung; Gwang Cheol Go; Sang Yoon Jeon; Sira Bang; Ki Hwa Lee; Yong Han Kim; Dong-Kie Kim
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.